Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Diamedica Therapeutics (DMAC – Research Report) today. The company’s shares closed yesterday at $6.61. See what stocks are ...
Through their vision and collaboration with DMAC Architecture & Interiors ... stone fireplace at the entrance pays homage to Taliesin East, the home and studio of Frank Lloyd Wright on the Wisconsin ...